Drug Shortage Report for SANDOZ SILODOSIN
| Report ID | 263638 |
| Drug Identification Number | 02475421 |
| Brand name | SANDOZ SILODOSIN |
| Common or Proper name | SILODOSIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | SILODOSIN |
| Strength(s) | 4MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 30HGC |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-07-28 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-07-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-07-29 | English | Compare |
| v2 | 2025-07-28 | French | Compare |
| v1 | 2025-07-28 | English | Compare |
Showing 1 to 3 of 3